Patent ID: 8614060
Filing Date: 2013-12-24
Classification: C12Q

Abstract:
1. A method of administering warfarin to a subject, the method comprising; genotyping a human subject in need of warfarin treatment at the position corresponding to 5808 of SEQ ID NO: 1; administering a maintenance dose of between 2.0 and 3.5 mg/day to a subject determined to have a genotype of G/G at the position corresponding to 5808 of SEQ ID NO: 1; or administering a maintenance dose of between 3.6 to 4.6 mg/day to a subject determined to have a genotype of T/G at the position corresponding to 5808 of SEQ ID NO:1; or administering a maintenance dose of between 4.8 to 5.7 mg/day to a subject determined to have a genotype of T/T at the position corresponding to 5808 of SEQ ID NO:1.